Literature DB >> 7796232

Concentrations of main serum opsonins in early infancy.

V Drossou1, F Kanakoudi, E Diamanti, V Tzimouli, T Konstantinidis, A Germenis, G Kremenopoulos, V Katsougiannopoulos.   

Abstract

The evolution of the main serum opsonins in neonates and infants of varying gestational age was investigated to provide reference values for these opsonins in early infancy. Serum concentrations of immunoglobulins, IgG subclasses, C3, C4 and fibronectin were serially measured from birth until the age of 6 months in term and preterm infants. Measurements were performed by rate nephelometry. Five hundred and sixty six neonates (gestational age 26-41 weeks) were examined at birth, 233 at 1 month, 218 at 3 months, and 147 at 6 months, respectively. The same measurements were performed in 54 pairs of neonatal/maternal samples and in 230 apparently healthy adults. Gestational age had a significant impact on serum IgG, IgG subclasses, C3 and C4 up till the third month, and on fibronectin until the first month. No such impact was observed for IgA and IgM. Sixteen per cent of the neonates had IgM concentrations higher than 0.2 g/l at birth, suggesting that the critical concentration of serum IgM at birth for suspected intrauterine infection should be reconsidered. Concentrations of all opsonins at birth were significantly lower than adult reference values. They only approached or even reached adult values by the third or the sixth month. Data from analysis of the neonatal and the corresponding maternal sera indicate that there is a preferential active transplacental transport of IgG subclasses in the order of IgG1, IgG3, IgG2 and IgG4. These results show that concentrations of immunoglobulins, C3, C4 and fibronectin undergo changes during the first months of life, depending not only on the infants' postnatal age but also on gestational age.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796232      PMCID: PMC2528447          DOI: 10.1136/fn.72.3.f172

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  19 in total

1.  IgG subclasses compared in maternal and cord serum and breast milk.

Authors:  A Gasparoni; A Avanzini; F Ravagni Probizer; G Chirico; G Rondini; F Severi
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  IgG-subclass concentrations in cord sera from premature, full term and small-for-dates babies.

Authors:  D Catty; R Seger; R Drew; J Ströder; H Metze
Journal:  Eur J Pediatr       Date:  1977-06-01       Impact factor: 3.183

3.  Serum complement (beta 1C) in young children with atopic dermatitis.

Authors:  H S Kaufman; O L Frick; D Fink
Journal:  J Allergy       Date:  1968-07

4.  Developmental aspects of the human complement system.

Authors:  M K Sawyer; M L Forman; L S Kuplic; E R Stiehm
Journal:  Biol Neonate       Date:  1971

5.  IgG subclass levels in infancy and childhood.

Authors:  V A Oxelius
Journal:  Acta Paediatr Scand       Date:  1979-01

6.  The placental transfer of IgG subclasses in human pregnancy.

Authors:  R W Pitcher-Wilmott; P Hindocha; C B Wood
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

7.  The transfer of human IgG subclasses from mother to foetus.

Authors:  F C Hay; M G Hull; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

8.  Serum immunoglobulin levels in premature and full-term infants.

Authors:  H E Evans; S O Akpata; L Glass
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

9.  IgG subclasses: development of the serum concentrations in "normal" infants and children.

Authors:  A Morell; F Skvaril; W H Hitzig; S Barandun
Journal:  J Pediatr       Date:  1972-06       Impact factor: 4.406

10.  Serum complement profiles in infants and children.

Authors:  M E Norman; E P Gall; A Taylor; L Laster; U R Nilsson
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

View more
  12 in total

1.  Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Is there an effect of immunoglobulins and G-CSF on neutrophil phagocytic activity in preterm infants?

Authors:  R Bialek; P Bartmann
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 4.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 5.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Induction and termination of inflammatory signaling in group B streptococcal sepsis.

Authors:  Julia Wennekamp; Philipp Henneke
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

7.  Phagocytic ability of neutrophils and monocytes in neonates.

Authors:  Athanasios Filias; Georgios L Theodorou; Sofia Mouzopoulou; Anastasia A Varvarigou; Stephanos Mantagos; Marina Karakantza
Journal:  BMC Pediatr       Date:  2011-04-14       Impact factor: 2.125

8.  Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2.

Authors:  Megan N Ballinger; Marc Peters-Golden; Bethany B Moore
Journal:  Respir Res       Date:  2011-12-05

Review 9.  Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease.

Authors:  Sybille Landwehr-Kenzel; Philipp Henneke
Journal:  Front Immunol       Date:  2014-10-29       Impact factor: 7.561

Review 10.  Postnatal Innate Immune Development: From Birth to Adulthood.

Authors:  Anastasia Georgountzou; Nikolaos G Papadopoulos
Journal:  Front Immunol       Date:  2017-08-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.